Embark Technology, Inc. f/k/a Northern Genesis Acquisition Corp. II
Embark develops self-driving software solutions for the trucking industry in the U.S. The Company was originally a special purpose acquisition company, also called a blank-check company, which is a development stage company that has no specific business plan or...
Abbvie Inc.
AbbVie is one of the worlds largest pharmaceutical companies. The companys revenues will come under significant pressure in the coming years when its best-selling drug, Humira, will lose patent protection in 2023. Accordingly, AbbVies future revenue and earnings...
PLAYSTUDIOS, Inc.
- Notes: The alleged class includes : All persons and entities other than defendants and other persons who purchased, or otherwise acquired securities of Playstudios, Inc. between June 22, 2021 and March 1, 2022, both dates inclusive. For More information as well as...
International Business Machines Corporation
- Notes: The alleged class includes : All persons and entities, other than Defendants, who purchased the securities of IBM during the period of April 4, 2017, and October 20, 2021, both dates inclusive. For More information as well as to join this case please contact...
Everbridge, Inc.
Everbridge is a software company that provides enterprise software applications to automate and accelerate organizations' operational response to "critical events" in order to keep people safe and organizations running. These critical events include public safety...
Volta Inc.
On August 26, 2021, Volta Industries, Inc. ("Legacy Volta"), a private entity, and Tortoise Acquisition Corp. II, a special purpose acquisition company, completed a business combination pursuant to which the combined entity was named Volta Inc. (the "Business...
Lucid Group, Inc.
Lucid, a Delaware corporation with principal executive offices in Newark, California, designs, engineers, builds, and sells luxury electric vehicles ("EVs"). Specifically, Lucid currently sells an electric sedan, the Lucid Air, and plans to launch an electric SUV, the...
Homology Medicines, Inc.
Homology, a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. The Company's lead product candidate is HMI-102, which is in Phase I/II pheNIX clinical trial, a gene therapy for the treatment of...
Vertiv Holdings Co.
On February 23, 2022, at 6:00 a.m. Eastern, Vertiv reported disappointing financial results, including $0.06 earnings per share for fourth quarter 2021, missing analyst estimates of $0.28 per share. Vertiv's Chief Executive Officer attributed the poor results to...
Cano Health, Inc. f/k/a Jaws Acquisition Corp.
Cano provides primary care medical services to its members in the United States and Puerto Rico. The Company owns and operates medical centers, as well as operates pharmacies. Cano used to be a special purpose acquisition company ("SPAC") and operated under the name...